TABLE 1.
Synergic compounds at 0.1 mM with AmB 0.03 μg/ml against C. neoformans
| Compound name | Amount (μg/ml) | Therapeutic class | Target/action mechanism | Compound inhibition (%) | Combination inhibition (%) |
|---|---|---|---|---|---|
| Atracurium besylate | 124 | Neuromuscular | Nondepolarizing neuromuscular blocking agent. Antagonizes the neurotransmitter action of acetylcholine | 40 | 95 |
| Erythromycin | 73 | Infectiology/metabolism | Inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits | 15 | 90 |
| Riluzole hydrochloride | 27 | Central nervous system | Inhibitory effect on glutamate release, inactivation of voltage-dependent sodium channels, and interference in intracellular events that follow transmitter binding at excitatory amino acid receptors | 25 | 95 |
| Nortriptyline hydrochloride | 30 | Central nervous system | Inhibits the reuptake of the neurotransmitter serotonin at the neuronal membrane or acts at beta-adrenergic receptors | 30 | 90 |
| Chenodiol | 40 | Gastroenterology | Suppresses hepatic synthesis of both cholesterol and cholic acid, gradually replacing the latter and its metabolite, deoxycholic acid, in an expanded bile acid pool | 30 | 90 |
| Thioguanosine | 31 | Metabolism/oncology | Antineoplastic action. Inhibits the synthesis of DNA and RNA of cells. | 40 | 85 |
| Diflorasone diacetate | 49 | Endocrinology | Synthetic glucocorticoid that binds to the glucocorticoid receptor (GR) in the cytoplasm. | 30 | 90 |
| Oxiconazole nitrate | 49 | Infectiology/metabolism | Inhibits ergosterol biosynthesis, inhibits DNA synthesis, and suppresses the intracellular concentrations of ATP | 5 | 95 |
| Nisoldipine | 39 | Cardiovascular | By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. Inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes | 25 | 95 |
| Promazine hydrochloride | 32 | Central nervous system | Antagonism at dopamine and serotonin type 2 receptors, with greater activity at serotonin 5-HT2 receptors than at dopamine type-2 receptors | 20 | 80 |
| Chlorcyclizine hydrochloride | 33 | Allergology/central nervous system | Histamine H1 receptor | 15 | 100 |
| Demeclocycline hydrochloride | 50 | Metabolism | Inhibits the translation by binding to the 30S and 50S ribosomal subunit, impairing protein synthesis. | 35 | 90 |
| Cloperastine hydrochloride | 36 | Respiratory | Not identified | 5 | 90 |
| Glimepiride | 49 | Endocrinology | Binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface. Reduces potassium conductance causing depolarization of the membrane and stimulates calcium ion influx through voltage-sensitive calcium channels. Induces the secretion of insulin | 5 | 80 |